타우린 관련 야간 통증성 수면 방해

Q: Does 타우린 help with 야간 통증성 수면 방해?

Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that 타우린 may support 야간 통증성 수면 방해 management. Our evidence grade is B (Good Evidence).

Q: How much 타우린 should I take for 야간 통증성 수면 방해?

Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of 타우린?

Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for 타우린 and 야간 통증성 수면 방해?

We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.

B 근거 적어도 하나의 무작위 시험이 이를 지지하며, 대체로 일관된 결과를 보입니다.

Taurine은 전임상 모델에서 항염 및 진통 특성을 나타냈습니다. 억제성 신경전달물질 활성은 야간 통증 인식을 줄이고 수면 연속성을 지원하는 데 도움이 될 수 있습니다. 통증 관련 수면 방해에 대한 임상 근거는 매우 제한적입니다.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dtaurine\u0026condition\u003Dnighttime\u002Dpain\u002Dsleep'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Key Study Findings

Controlled Clinical Trial n=32 12 weeks Open-label

Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …

Dose: None vs: Standard care alone Outcome: Itch and insomnia improvement in atopic dermatitis 효과: None 0.0449 (itch), 0.0089 (insomni

대상 집단: Patients with atopic dermatitis and mild-moderate negative emotions

Other

Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.

Dose: None vs: None Outcome: None 효과: None p < .05

대상 집단: Insomnia patients

Review

Commonly encountered symptoms and their management in patients with cirrhosis.

Dose: None vs: None Outcome: Pain outcomes 효과: None None

대상 집단: Insomnia patients

Observational Study

[Energy drink consumption patterns and its adverse effects on adolescent health.].

Dose: None vs: None Outcome: Energy drink consumption and adverse effects 효과: None None

대상 집단: Adolescents

Other

[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …

Dose: None vs: None Outcome: rat model of cardiorenal insomnia from in vitro … 효과: None None

대상 집단: None

Review

Assessment and treatment of insomnia in adult patients with alcohol use disorders.

Dose: None vs: None Outcome: None 효과: None None

대상 집단: insomnia patients

Key Statistics

연구

참여자

↔

Mixed

등급

Referenced Papers

Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. Other

Asian Pacific journal … 2025 6 인용

Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. Other

PloS one 2024 5 인용

Commonly encountered symptoms and their management in patients with cirrhosis. Review

Frontiers in medicine 2024 4 인용

[Energy drink consumption patterns and its adverse effects on adolescent health.]. Other

Revista espanola de … 2022 2 인용

[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. Other

Zhongguo Zhong yao … 2020 5 인용

Assessment and treatment of insomnia in adult patients with alcohol use disorders. Review

Alcohol (Fayetteville, N.Y.) 2015 122 인용

The clinical pharmacology of acamprosate. Review

British journal of … 2014 111 인용

Pharmacological treatment of insomnia in alcohol recovery: a systematic review. Systematic Review

Alcohol and alcoholism … 2011 40 인용

Safety issues associated with commercially available energy drinks. Review

Journal of the … 2008 300 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

sleep:: 500-2,000 mg, 1 hour before bed

상한량: 3,000 mg/day considered safe in clinical studies

연구에서 사용된 용량

용량	기간	효과	N
None	12 weeks	Positive	32
None	--	Neutral	--
None	--	Neutral	--
None	--	Mixed	--
None	--	Mixed	--
None	--	Positive	--
None	--	Positive	--
None	--	Mixed	--

권장 복용 시간: 1 hour before bed

Safety & Side Effects

보고된 부작용

⚠ Generally well tolerated
⚠ Mild GI discomfort at high doses
⚠ Drowsiness (desired for sleep use)

알려진 상호작용

● Lithium — taurine may alter lithium excretion
● Antihypertensives — may have additive blood pressure lowering effects
● CNS depressants — potential additive sedative effects

일일 최대 섭취 허용량: 3,000 mg/day considered safe in clinical studies

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 타우린 help with 야간 통증성 수면 방해?

Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that 타우린 may support 야간 통증성 수면 방해 management. Our evidence grade is B (Good Evidence).

How much 타우린 should I take for 야간 통증성 수면 방해?

Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of 타우린?

Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for 타우린 and 야간 통증성 수면 방해?

We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.

타우린 다른 건강 상태에 대한 근거

불면증 B 입면 장애 B

한눈에 보기

Taurine은 전임상 모델에서 항염 및 진통 특성을 나타냈습니다. 억제성 신경전달물질 활성은 야간 통증 인식을 줄이고 수면 연속성을 지원하는 데 도움이 될 수 있습니다. 통증 관련 수면 방해에 대한 임상 근거는 …

Evidence Strength72%

High confidence

연구 분석

RCT (0)Meta (0)Other (9)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: 야간 통증성 수면 방해

자세히 알아보기

References

[1] Wanying Zhai et al.. Asian Pac J Allergy Immunol. 2025. Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. doi:10.12932/AP-100223-1542 PubMed
[2] Williams Kobik et al.. PLoS One. 2024. Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. doi:10.1371/journal.pone.0289391 PubMed
[3] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
[4] Paola Silva Maldonado et al.. Rev Esp Salud Publica. 2022. [Energy drink consumption patterns and its adverse effects on adolescent health.]. PubMed
[5] Yu-Han Yang et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. doi:10.19540/j.cnki.cjcmm.20190524.502 PubMed
[6] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
[7] Nicola J Kalk et al.. Br J Clin Pharmacol. 2014. The clinical pharmacology of acamprosate. doi:10.1111/bcp.12070 PubMed
[8] Bhanu Prakash Kolla et al.. Alcohol Alcohol. 2011. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. doi:10.1093/alcalc/agr073 PubMed
[9] Kevin A Clauson et al.. J Am Pharm Assoc (2003). 2008. Safety issues associated with commercially available energy drinks. doi:10.1331/JAPhA.2008.07055 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.